A 28-year-old Japanese man presented with upper abdominal pain. Computed tomography (CT) revealed a soft tissue mass in the small bowel mesentery. We diagnosed the patient with sclerosing mesenteritis according to the histological findings of small bowel mesentery. Although he was treated with prednisolone, colchicine and azathioprine, neither his symptoms nor CT findings improved. This case is rare in that the disease was refractory. The characteristics of Japanese patients with sclerosing mesenteritis involving small bowel mesentery are not well understood. We herein describe the details of such patients based on a literature review including 32 recently reported Japanese cases.
Introduction
Sclerosing mesenteritis is a rare idiopathic disorder that affects the adipose tissue of the mesentery with varying degrees of fat necrosis, inflammation and fibrosis (1) . Although the natural history of this disease is not well understood, many patients exhibit a good response to treatment and with a good prognosis. The disease usually involves the small bowel mesentery in Western patients (2) , in contrast to the large bowel mesentery in Japanese patients (3, 4) . In particular, the sigmoid mesentery is most frequently involved among the large bowel mesentery in Japanese patients (3, 4) . Therefore, the major portion of the mesentery involved in sclerosing mesenteritis appears to differ between races. However, the reasons for this difference have not been clarified. The characteristics of Japanese patients with sclerosing mesenteritis involving the small bowel mesentery are also not well understood.
In this report, we present a rare Japanese case of refractory sclerosing mesenteritis involving the small bowel mesentery. We describe the details of our patient and provide a literature review including recent Japanese case reports in order to compare the various presentations, etiologies, diagnoses and treatments for sclerosing mesenteritis.
Case Report
A 28-year-old Japanese man was admitted to our hospital with a three-month history of upper abdominal pain. The upper abdominal pain had been increasing gradually since onset, and severe pain persisted throughout almost the entire day of admission. The patient exhibited no changes in bowel habits or body weight loss. He had no past history of any diseases, including abdominal surgery or trauma, and no history of medication use. He also had no history of smoking On admission, the patient was 170 cm tall and weighed 65 kg. His vital signs were stables, with no fever. A physical examination revealed abdominal tenderness, a palpable mass in the upper abdomen and slight pitting edema of the lower extremities.
The laboratory findings (Table 1 ) indicated low levels of total protein, albumin and IgG. A blood cell count and the C-reactive protein, IgE and IgG4 levels were normal. Antinuclear antigens were negative.
Abdominal dual-phase computed tomography (CT) disclosed a soft tissue mass in the small bowel mesentery (Fig. 1) . Abdominal magnetic resonance imaging (MRI) also demonstrated a soft tissue mass in the small bowel mesentery, similar to the CT findings. The image of the pancreas was normal on both CT and MRI. Positron emission tomography (PET) combined with CT was negative. Gastroduodenoscopy and total colonoscopy showed no abnormal findings. Radiography of the small intestine indicated slight edema in the jejunum. Per oral double-balloon enteroscopy (DBE) revealed mucosal edema, white villi, white nodules and white debris in the third portion of the duodenum and jejunum (Fig. 2) . A histological examination of the biopsy specimens obtained from the jejunal mucosa demonstrated infiltration of chronic inflammatory cells and lymphangiectasia (Fig. 3A, B) . Immunohistochemically, there were no IgG4-positive cells in the specimens (Fig. 3C ) and no evidence of malignancy, including carcinoma or lymphoma. Based on these findings, a diagnosis of sclerosing mesenteritis was highly suspected. In order to obtain pathological confirmation and completely exclude the possibility of malignancy, we performed an open surgical biopsy under general anesthesia. The gross findings of laparotomy included diffuse mesenteric thickening that formed a mass lesion in the jejunal mesentery (Fig. 4A, B) . Additionally, the portion of the jejunum affected by the mesenteric mass appeared edematous, and dilated lymphatic vessels were noted on the surface of the jejunal serosa (Fig. 4C) . A histological examination of the thickened mesentery revealed fat necrosis with foamy macrophages and infiltration of chronic inflammatory cells (Fig. 5A, B) . No apparent fibrosis was observed. Immunohistochemically, there were no IgG4-positive cells in the specimens (Fig. 5C ). Therefore, we finally diagnosed the patient with sclerosing mesenteritis.
Treatment with 30 mg of prednisolone once daily was started; however, the patient's symptoms (upper abdominal pain and pretibial edema) did not improve. Therefore, the daily dose of prednisolone was gradually reduced every two weeks. A follow-up CT scan performed four weeks after the first administration of prednisolone revealed that the mass lesion in the mesentery had not changed. Although we additionally administered colchicine and azathioprine, the patient exhibited no response to these treatments. A follow-up CT scan performed approximately 1.5 years after symptom onset demonstrated that the mass lesion in the mesentery remained unchanged. The patient now receives follow-up visits and takes pain-relieving drugs.
Discussion
Sclerosing mesenteritis is a rare, idiopathic, benign, chronic fibrosing inflammatory disease that affects the adipose tissue of the mesentery (5, 6) .
Since the disease was first reported in 1924, various cases have been reported in the literature under several terms: retractile mesenteritis, sclerosing mesenteritis, mesenteric panniculitis, mesenteric lipodystrophy and so on. In these reports, the patients exhibited various pathological features, including fat necrosis, chronic inflammation and fibrosis. In recent years, these histological variants have been thought to be based on a single pathological entity characterized by nonspecific chronic inflammatory infiltration and fibrosis in mesenteric fat. Adipocyte necrosis (mesenteric lipodystrophy) is thought to progress to a chronic inflammatory state (mesenteric panniculitis) and finally to fibrosis (sclerosing mesenteritis). Therefore, sclerosing mesenteritis may be the best proposed umbrella term (1, 2) . In the present case, fat necrosis and infiltration of chronic inflammatory cells were observed in the histological findings; however, no apparent fibrosis was detected. Therefore, in the narrow sense, the strict histological diagnosis was mesenteric panniculitis. However, as mentioned above, "sclerosing mesenteritis" is thought be the best diagnosis to represent the patient's condition as an umbrella term.
Most studies from Western countries have indicated that sclerosing mesenteritis is more common in men than women, on the order of 2:1. Most patients are in the fifth to seventh decades of life, with a median age of 65 years (2) . Pediatric cases are rare because children have lower amounts of mesenteric fat than adults (7) . In Western patients, the disease usually involves the small bowel mesentery. Although some patients with involvement of the sigmoid mesentery have been reported (1, (8) (9) (10) , such cases are very rare. On the other hand, in Japanese patients, the disease often involves the large bowel mesentery (3, 4). Mizutani et al. examined 109 Japanese patients and reported that only 36% had small bowel mesentery involvement, while 58%
Figure 5. The microscopic findings showed fat necrosis with foamy macrophages (A) and chronic inflammation (B). Immunohistochemically, there were no IgG4-positive cells (C). (A) Hematoxylin and Eosin (H&E) staining, ×2, (B) H&E staining, ×10, (C) Immunohistochemical staining for IgG4, ×10
had large bowel mesentery involvement (11) . The authors also found that the sigmoid mesentery was most frequently involved among the large bowel mesentery (11) . Therefore, the portion of the mesentery most frequently involved in sclerosing mesenteritis appears to differ between races. Although some genetic factors may potentially be involved, the precise reasons underlying these differences have not been clarified.
The characteristics of Japanese patients with sclerosing mesenteritis involving the small bowel mesentery are not well understood. In order to elucidate the background factors and clinical courses of such patients, we reviewed recent Japanese cases. We conducted a comprehensive search of MEDLINE /PubMed and ICHUSHI from 2000 to July 2013 using the term "sclerosing mesenteritis" and extracted 32 case reports of Japanese patients with sclerosing mesenteritis involving the small bowel mesentery. The demographic and clinical characteristics of the 33 patients, including the present patient, are summarized in Table 2 . The average age at diagnosis was 61±16.3 years (mean ± S.D.), and 25 of the 33 patients (76%) were men. Seven patients contracted the disease after abdominal surgery, while four patients also had chylous ascites and one patient also had protein-losing enteropathy (12) . Although the evidence was insufficient for verification, our patient was also presumed to have, with a relatively high probability, protein-losing enteropathy, according to the serologic, endoscopic and histological findings. In addition, one patient had IgG4-related sclerosing mesenteritis (13) . As for the diagnostic method used in each case, 12 patients were diagnosed using CT scans only, 11 patients were diagnosed using open surgical biopsies and 10 patients were diagnosed based on the pathological findings of the surgically removed involved mesentery. As for treatment, 21 of the 33 cases were managed with medical treatment only (Table 3 ). In the medical treatment group, steroids were administered in 12 of the 21 cases, and only one of these patients (our patient) was resistant to steroid therapy. Twelve of the 33 patients were treated surgically (Table 4 ). In four of these 12 cases, surgery was performed in order to make a histological diagnosis. In these four cases, it was necessary to rule out the presence of malignant tumors histologically because the involved mesentery formed mass lesions. Three cases underwent surgery due to the presence of ileus, three patients underwent surgery due to resistance to conservative therapy and two patients underwent surgery to control acute symptoms. As for the operative procedures, resection of the small intestine was performed in nine of the 12 surgical interventions; the operation was performed successfully in 11 cases. The clinical courses of the 11 successfully treated patients were good. However, intended resection of the involved lesion was impossible in one case, and the patient was reported to have died after the surgery. Overall, in 30 of the 33 cases (91%), the clinical course after medical treatment or surgical intervention was adequate to improve the patient's condition. However, three patients, including ours, were resistant to therapy, two of whom died (not including our patient). According to this review, Japanese patients with sclerosing mesenteritis involving the small bowel mesentery generally have characteristics similar to those of Western patients. The present patient appears to be rare in that the disease was refractory. The precise etiology of sclerosing mesenteritis remains unknown. However, the disease appears to be caused by a nonspecific response to a wide variety of stimuli, including abdominal surgery or trauma (1, 2, 14) , autoimmunity (15) (16) (17) (18) (19) (20) , malignancy (1, 21, 22) , ischemic injury and infection (23) . Other factors have also been reported, such as chronic inflammatory conditions, collagen vascular diseases (2) and IgG-4 related disease (24) . In the present case, none of the associated conditions described above were identified.
A variety of clinical manifestations of sclerosing mesenteritis have been described, and several asymptomatic cases have been reported (1, 2, 21) . Many of these cases were diagnosed incidentally when the patients underwent radiologic procedures for other indications (21) . As for symptomatic cases, the most common presenting manifestations are abdominal pain, nausea, vomiting, altered bowel habits, anorexia, body weight loss and palpable abdominal masses (1, 2, 14) . In the present case, both upper abdominal pain and a palpable abdominal mass were observed, and the area of abdominal pain completely accorded with the location of the palpable mass. There were no abnormalities, such as gastroduodenal ulcers, pancreatitis or gallbladder stones, that may have caused abdominal pain. Therefore, the patient's abdominal pain was strongly believed to have been caused by the sclerosing mesenteritis itself. Because the symptoms of sclerosing mesenteritis are nonspecific and varied, it is important to consider the possibility of this condition when examining patients with such symptoms.
Laboratory findings are not crucial for diagnosing sclerosing mesenteritis. Although an increased erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) level may be The case numbers are same as those in Table 2 .
found in a minor proportion of patients, the laboratory findings in many patients are normal. In the present case, low levels of total protein, albumin and IgG were found, and hypoproteinemia likely induced the bilateral pretibial edema observed in our patient. Based on the endoscopic and histological findings of the jejunal mucosa, the above conditions were presumably caused by protein loss from the dilated lymphatic vessels of the jejunum. We speculate that the mesenteric mass disturbed the lymph flow in the ducts, inducing leakage of lymphatic fluid from the dilated lymphatic vessels as a secondary change. Radiographic findings are essential for diagnostically evaluating sclerosing mesenteritis, with abdominal CT being the most sensitive imaging modality for diagnosis. The CT findings of the disease are varied, depending on the predominant tissue component (inflammatory phase or fibrotic phase) (2, 21) . The most common finding is the presence of a soft tissue mass in the mesentery. Mass lesions are visualized as more heterogeneous in cases involving the inflammatory phase and more homogeneous in those involving the fibrotic phase. Calcification and cystic changes may also been seen, likely due to a necrotic process.
Additionally, the following two characteristic appearances have been proposed to be specific findings of sclerosing mesenteritis: 1) a "fat ring sign" and 2) the presence of a "tumoral pseudocapsule" (15, (25) (26) (27) . The "fat ring sign" represents the preservation of fat nearest the mesenteric vessels (26, 28) , while the presence of a "tumoral pseudocapsule" represents a band of soft tissue separating the uninvolved mesentery from the inflamed fat (21, 25) . In the present case, a heterogeneous mass was found at the root of the small bowel mesentery and a "tumoral pseudocapsule" was detected, indicating that the patient had the typical CT findings of sclerosing mesenteritis.
The final and definitive diagnosis of sclerosing mesenteritis can be established based on a histologic examination of the mesentery. Histologically, the disease appears to progress in three consecutive stages: from mesenteric lipodystrophy to mesenteric panniculitis to retractile mesenteritis. Therefore, the histologic findings may reveal fat necrosis, chronic inflammation, fibrosis or a combination of any two or all three of these conditions (1, 2, 29) . In the present case, a histological examination of the thickened mesentery revealed infiltration of lymphocytes with adipocyte necrosis, indicating that the disease had progressed to the stage of mesenteric lipodystrophy or mesenteric panniculitis without the development of fibrosis.
There is no consensus regarding medical therapy for sclerosing mesenteritis. Asymptomatic cases can be managed without medication. As for symptomatic patients, the treatment is usually empiric and individualized. Some symptomatic patients have been reported to improve following treatment with corticosteroids (2, 30, 31) . In addition to corticosteroids, colchicine (32, 33) , azathioprine (34, 35) , cyclophosphamide (36) , thalidomide (37) and tamoxifen (2, 38, 39) have been reported to be beneficial. However, the regimen for managing sclerosing mesenteritis has not been established because the use of the above medications has only been reported in small case series. Performing surgical resection of the lesion is quite difficult due to the presence of associated vascular compromise and the extent of disease. Therefore, surgery should be attempted only in patients with severe complications, such as intestinal obstruction or perforation (40) . In the present case, neither the patient's symptoms nor radiographic findings improved after treatment with corticosteroids, colchicine and azathioprine. However, surgical resection was not performed because the small bowel mesentery of the jejunum was shown to be widely involved on the CT scan and gross findings during laparotomy. If we had performed surgical resection of the involved lesion, quite a long segment of the jejunum would have needed to be removed. Such an operation could, with high probability, result in short bowel syndrome. Therefore, we did not perform short bowel resection. Fortunately, the patient's symptoms were relatively mild, and he continues to be observed at our hospital as an outpatient while receiving pain control.
In conclusion, we herein presented a rare Japanese case of refractory sclerosing mesenteritis involving the small bowel mesentery and reviewed the literature, including 32 recent Japanese case reports. According to our review, Japanese patients with sclerosing mesenteritis involving the small bowel mesentery generally have characteristics similar to those of Western patients. The present case appears to be rare in that the disease was refractory and possibly accompanied by protein-losing enteropathy. The etiology of sclerosing mesenteritis is not well understood, nor is the reason why the major portion of the mesentery frequently involved in such patients differs between races. Furthermore, differences between the small bowel mesentery type and large bowel mes- The case numbers are same as those in Table 2 .
entery type have not been clarified, and there is no standardized treatment for the disease. In particular, there is little information regarding Japanese cases involving the small bowel mesentery. The accumulation of additional case studies is required to understand this disease.
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